Cantargia AB (OSTO:CANTA) Net Change in Cash : kr-105.65 Mil (TTM As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Cantargia AB Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Cantargia AB's Net Change in Cash for the three months ended in Dec. 2024 was kr-25.71 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was kr-105.65 Mil.

Cantargia AB Net Change in Cash Historical Data

The historical data trend for Cantargia AB's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cantargia AB Net Change in Cash Chart

Cantargia AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

653.48

-446.04

-57.75

-49.83

-106.71

Cantargia AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Change in Cash	Get a 7-Day Free Trial															-34.94	-32.14	-22.92	-24.87	-25.71

Cantargia AB Net Change in Cash Calculation

Cantargia AB's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-162.752	+	55	+	-1.066	+	2.107
	=	-106.71

Cantargia AB's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -26.266 + 0 + 0 + 0.556

= -25.71

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-105.65 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantargia AB Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Cantargia AB's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Cantargia AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cantargia AB (OSTO:CANTA) » Definitions » Net Change in Cash

Comparable Companies

OSTO:INIT OSTO:IVACC OSTO:XBRANE OSTO:LIPUM OSTO:ISOFOL OSTO:ONCO OSTO:IRLAB A OSTO:IMMU OSTO:XINT OSTO:ACE VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX

Traded in Other Exchanges

7V3:Germany

Address

Scheelevagen 27, Lund, SWE, SE-223 63

Website

https://www.cantargia.com

Cantargia AB is engaged in the development of products used in the treatment of cancer. It has developed specific antibodies against IL1RAP to treat serious, life-threatening diseases. The company's first product candidate, CAN04, has also been designed to treat different forms of cancer, with the initial focus on the treatment of non-small cell lung cancer and pancreatic cancer. The CAN10 project covers a disease segment that complements nadunolimab and diversifies Cantargia's project portfolio.

Cantargia AB Headlines

No Headlines